Jennifer Peppe files SEC Form 4 disclosures for Imago BioSciences, Inc.. They have made 7 open-market trades across 1 company since 2022, most recently 2023-01-11.
CIK 0001861060
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IMGO | 150,188 | $5.4M |
Shares reported on the most recent Form 4, priced at the 2023-01-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMGO | SELL | 2022-12-15 | 2022-12-19 | $35.80 | $8.6M | +0.4% | N/A | N/A |
| IMGO | SELL | 2022-08-16 | 2022-08-17 | $19.41 | $249K | -22.4% | -14.4% | -6.0% |
| IMGO | SELL | 2022-08-15 | 2022-08-16 | $19.41 | $217K | -17.8% | -13.7% | -6.0% |
| IMGO | SELL | 2022-02-11 | 2022-02-15 | $23.76 | $166K | -1.8% | -16.8% | -36.9% |
| IMGO | SELL | 2022-02-09 | 2022-02-11 | $22.26 | $445K | -5.4% | -17.3% | -43.8% |
| IMGO | SELL | 2022-02-07 | 2022-02-09 | $20.48 | $266K | +1.2% | +8.8% | -32.5% |
| IMGO | SELL | 2022-01-12 | 2022-01-14 | $19.95 | $279K | -3.5% | +26.3% | +2.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.